Amy Langdon

1.7k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Amy Langdon is a scholar working on Molecular Biology, Infectious Diseases and Surgery. According to data from OpenAlex, Amy Langdon has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Amy Langdon's work include Clostridium difficile and Clostridium perfringens research (6 papers), Gut microbiota and health (6 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Amy Langdon is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (6 papers), Gut microbiota and health (6 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Amy Langdon collaborates with scholars based in United States, Australia and United Kingdom. Amy Langdon's co-authors include Gautam Dantas, Nathan Crook, Drew J. Schwartz, Manuel Martínez‐García, Emily J. Fleming, Ramūnas Stepanauskas, Nicole Poulton, David Emerson, Xiaoqing Sun and Erik R. Dubberke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Amy Langdon

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

2016 627 citations Amy Langdon, Nathan Crook et al. Genome Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Langdon United States	8	582	288	132	130	113	14	1.1k
Anette Friedrichs Germany	9	657 1.1×	303 1.1×	143 1.1×	121 0.9×	133 1.2×	17	1.0k
Yan Shao United Kingdom	9	970 1.7×	274 1.0×	203 1.5×	180 1.4×	113 1.0×	19	1.4k
Antonella Gagliardi Italy	13	590 1.0×	295 1.0×	132 1.0×	241 1.9×	75 0.7×	18	1.2k
Dhrati Patangia Ireland	10	645 1.1×	169 0.6×	154 1.2×	100 0.8×	60 0.5×	19	1.1k
Robyn Baker United States	18	821 1.4×	255 0.9×	176 1.3×	261 2.0×	183 1.6×	27	1.7k
Léonard Dubois Italy	3	884 1.5×	195 0.7×	152 1.2×	147 1.1×	141 1.2×	3	1.2k
Sagun Maharjan United States	3	880 1.5×	188 0.7×	147 1.1×	144 1.1×	143 1.3×	4	1.2k
Ye Peng China	17	549 0.9×	148 0.5×	88 0.7×	76 0.6×	125 1.1×	54	1.0k
Dhiraj Dhotre India	21	745 1.3×	202 0.7×	118 0.9×	125 1.0×	157 1.4×	62	1.4k

Countries citing papers authored by Amy Langdon

Since Specialization

Citations

This map shows the geographic impact of Amy Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Langdon more than expected).

Fields of papers citing papers by Amy Langdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Langdon. The network helps show where Amy Langdon may publish in the future.

Co-authorship network of co-authors of Amy Langdon

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Langdon. A scholar is included among the top collaborators of Amy Langdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Langdon. Amy Langdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wilson, Gemma, et al.. (2025). Symptom burden, quality of life, and diagnostic journey of people with postural orthostatic tachycardia syndrome, Australia, 2021–24: a descriptive patient registry data study. The Medical Journal of Australia. 223(3). 159–160. 1 indexed citations

Langdon, Amy, et al.. (2025). Understanding the audiological care of patients with co-existing dementia or mild cognitive impairment and hearing loss in the United Kingdom National Health Service: A qualitative study. PLoS ONE. 20(6). e0327248–e0327248.

Langdon, Amy, et al.. (2023). 1615 RECOMMENDATIONS FOR THE ASSESSMENT AND MANAGEMENT OF CO-EXISTING DEMENTIA AND HEARING LOSS WITHIN UK AUDIOLOGY SERVICES. Age and Ageing. 52(Supplement_2). 2 indexed citations

Schwartz, Drew J., Amy Langdon, Xiaoqing Sun, et al.. (2023). Effect of amoxicillin on the gut microbiome of children with severe acute malnutrition in Madarounfa, Niger: a retrospective metagenomic analysis of a placebo-controlled trial. The Lancet Microbe. 4(11). e931–e942. 7 indexed citations

Gallagher, Celine, et al.. (2023). High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning. The American Journal of Medicine. 138(2). 354–361.e1. 36 indexed citations

Gallagher, Celine, et al.. (2023). Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population. Clinical Autonomic Research. 33(4). 469–477. 11 indexed citations

Langdon, Amy, Drew J. Schwartz, Xiaoqing Sun, et al.. (2021). Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study. Genome Medicine. 13(1). 28–28. 59 indexed citations

Schwartz, Drew J., Amy Langdon, & Gautam Dantas. (2021). Correction to: Understanding the impact of antibiotic perturbation on the human microbiome. Genome Medicine. 13(1). 26–26. 1 indexed citations

Schwartz, Drew J., Amy Langdon, & Gautam Dantas. (2020). Understanding the impact of antibiotic perturbation on the human microbiome. Genome Medicine. 12(1). 82–82. 195 indexed citations

10.

Langdon, Amy, Tiffany Hink, Meghan A. Wallace, et al.. (2018). Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential. mSphere. 3(6). 15 indexed citations

11.

Langdon, Amy, Nathan Crook, & Gautam Dantas. (2016). The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Medicine. 8(1). 39–39. 627 indexed citations breakdown →

12.

Langdon, Amy, Tiffany Hink, Meghan A. Wallace, et al.. (2016). Impact of Amoxicillin/Clavulanate and Autologous Fecal Microbiota Transplantation (FMT) on the Fecal Microbiome and Resistome. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

13.

Gökçümen, Ömer, Verena Tischler, Jelena Tica, et al.. (2013). Primate genome architecture influences structural variation mechanisms and functional consequences. Proceedings of the National Academy of Sciences. 110(39). 15764–15769. 43 indexed citations

14.

Fleming, Emily J., Amy Langdon, Manuel Martínez‐García, et al.. (2011). What's New Is Old: Resolving the Identity of Leptothrix ochracea Using Single Cell Genomics, Pyrosequencing and FISH. PLoS ONE. 6(3). e17769–e17769. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact